Hospitalised patients with decompensated cirrhosis are in a rebalanced haemostatic state
due to a parallel decline in both pro-and anti-haemostatic pathways. However, this …

Background Cirrhosis is the outcome of chronic liver disease of any etiology due to
progressive liver injury and fibrosis. Consequently, cirrhosis leads to portal hypertension …

Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as
jaundice and coagulopathy with the development of ascites, with a high probability of …

The coronavirus pandemic has resulted in increased rates of hepatic decompensation,
morbidity and mortality in patients suffering from existing liver disease, and deranged liver …

Background About 20% of patients infected with SARS-CoV-2 develop COVID-19—the
disease that has dominated health care in the last two years. The course of COVID-19 in …

Introduction Thromboelastography (TEG) provides a global assessment of hemostasis and
may have value for patients with cirrhosis who have multiple hemostatic defects. We sought …

Background and aims Coagulopathic bleeding risk prediction is challenging in
decompensated cirrhosis (DC) by conventional assays. Viscoelastic tests (VETs) are likely to …

Objectives Coagulation changes associated with COVID-19 suggest the presence of a
hypercoagulable state with pulmonary microthrombosis and thromboembolic complications …

Purpose Data regarding the incidence of a coagulable state following heat stroke as
assessed by Sonoclot signature analysis are limited. Our purpose was to appraise …

Introduction Patients with cirrhosis are known to be prone to infections. Infections can trigger
organ failures and decompensations in cirrhosis. Septic shock can increase mortality by …